RA
XBI icon

RFG Advisory’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

RFG Advisory’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-5,500
Closed -$487K – 551
2021
Q4 		$487K Buy
+5,500
New +$663K 0.03% 314

Other funds holding XBI

PR
PSP Research Newtown Square, Pennsylvania $188M AUM
AAS
Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return
WAM
Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return
RFM
Royal Fund Management Lady Lake, Florida $1.2B AUM 32.21% 1-Year Est. Return
NHFG
New Harbor Financial Group Worcester, Massachusetts $633M AUM 37.53% 1-Year Est. Return
MFS
Madrona Financial Services Everett, Washington $543M AUM 30.87% 1-Year Est. Return
LRPA
L. Roy Papp & Associates Phoenix, Arizona $951M AUM 29.05% 1-Year Est. Return
SGH
Sivik Global Healthcare Greenwich, Connecticut $132M AUM 24.1% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return
EWM
Edge Wealth Management New York $594M AUM 24.92% 1-Year Est. Return

RFG Advisory's XBI Position: Q2 2026 in Review

RFG Advisory opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q2 2026: 7,063 shares worth $1.12M. The stake represents 0.02% of the portfolio and ranks #536 among its holdings. This is a return to the name: RFG Advisory previously reported a position in XBI as recently as Q4 2025.

RFG Advisory first reported a position in XBI in Q2 2020 and has held it in 12 quarters since. 293 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • RFG Advisory held 7,063 shares of State Street SPDR S&P Biotech ETF worth $1.12M as of Q2 2026.
  • State Street SPDR S&P Biotech ETF was a new RFG Advisory position in Q2 2026.
  • State Street SPDR S&P Biotech ETF made up 0.02% of RFG Advisory's portfolio in Q2 2026, its #536 holding.
  • RFG Advisory first reported a position in State Street SPDR S&P Biotech ETF in Q2 2020 and has held it in 12 quarters since.
  • 293 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on RFG Advisory's 13F filing for Q2 2026, filed 15 Jul 2026.